Krystal Biotech
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
26.1416.6812.9510.42
Price/Sales ratio
8.415.944.423.63
Earnings per Share (EPS)
$5.50$8.63$11.11$13.81

Historical Multiples (2016 – 2023)

2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-39.55-7.12-21.37-46.13-35.04-22.31-14.42308.15-15.23-46.13
Price/Sales ratio
N/AN/A226.67N/AN/AN/AN/A66.44N/AN/A
Price/Book Value ratio
157.401.132.054.333.852.613.864.324.084.08
Price/Cash Flow ratio
-34.69-14.49-24.64-47.05-43.21-32.38-20.08-37.93-21.20-47.05
Price/Free Cash Flow ratio
-34.30-13.75-19.93-35.06-27.54-13.35-13.15-33.48-13.88-35.06
Price/Earnings Growth ratio
N/A-0.010.62-1.94-0.82-0.26-0.19-2.870.20-1.94
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A86.27%N/AN/AN/AN/A93.89%N/AN/A
Operating Profit Margin
N/AN/A-1160.27%N/AN/AN/AN/A-216.42%N/AN/A
Pretax Profit Margin
N/AN/A-1060.27%N/AN/AN/AN/A25.43%N/AN/A
Net Profit Margin
N/AN/A-1060.27%N/AN/AN/AN/A21.56%N/AN/A
Effective Tax Rate
N/AN/A0.18%-3.01%-5.11%-3.92%-24.32%15.23%N/A-3.01%
Return on Assets
-52.70%-15.80%-9.37%-9.13%-10.34%-11.10%-25.06%1.33%-25.06%-10.34%
Return On Equity
-397.92%-16.00%-9.61%-9.40%-11.01%-11.72%-26.80%1.40%-25.79%-11.01%
Return on Capital Employed
-53.43%-9.64%-10.49%-10.73%-11.17%-11.36%-27.41%-13.97%-22.69%-11.17%
Liquidity Ratios
Current Ratio
N/A77.9943.3958.8717.80N/AN/AN/A13.3017.80
Quick Ratio
50.4477.9943.3958.8717.8017.1813.3017.5513.1417.80
Cash ratio
44.7277.4839.9356.3617.3613.255.6110.825.6117.36
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A302.66N/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A824.02N/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A1.12KN/AN/A
Days of Payables Outstanding
7.66K3.06K2.29K271.31415.081.10K358.33218.12N/A415.08
Cash Conversion Cycle
N/AN/A-2.29KN/AN/AN/AN/A908.55N/AN/A
Debt Ratios
Debt Ratio
0.84N/AN/A0.000.02N/A0.000.000.060.00
Debt Equity Ratio
6.37N/AN/A0.000.02N/A0.000.000.060.00
Long-term Debt to Capitalization
0.86N/AN/AN/AN/AN/AN/AN/A0.01N/A
Total Debt to Capitalization
0.86N/AN/A0.000.02N/A0.000.000.010.00
Interest Coverage Ratio
N/A-1.51-11.60N/AN/AN/AN/AN/A-23.01N/A
Cash Flow to Debt Ratio
-0.71N/AN/A-38.98-3.16N/A-64.42-60.24-11.25-38.98
Company Equity Multiplier
7.551.011.021.031.061.051.061.051.061.03
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-9.19N/AN/AN/AN/A-1.75N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.051.231.341.562.421.521.131.521.34
Cash Flow Coverage Ratio
-0.71N/AN/A-38.98-3.16N/A-64.42-60.24-11.25-38.98
Short Term Coverage Ratio
N/AN/AN/A-38.98-3.16N/A-64.42-60.24-64.42-3.16
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A